|
Areas reviewed: Clinical and epidemiology research, except hematologic malignancies and psychosocial and behavioral research; and nonhematologic preclinical research which is translatable to the clinical arena, including diagnosis and therapy.
Richard A. Gams, MD, Chair
Prologue Research International, Columbus, OH
Michael Bouvet, MD, Vice Chair
University of California, San Diego, CA
Hossein Borghaei, DO
Fox Chase Cancer Center, Philadelphia, PA
Anees B. Chagpar, MD, MSc
University of Louisville, Louisville, KY
Joseph F. Costello, PhD
University of California, San Francisco, CA
Bevin Page Engelward, ScD
Massachusetts Institute of Technology, Cambridge, MA
David M. Euhus, MD
University of Texas Southwestern Medical Center, Dallas, TX
Kenneth A. Iczkowski, MD
University of Colorado Health Sciences Center, Aurora, CO
Martin R. Johnson, PhD
University of Alabama, Birmingham, AL
Badrinath R. Konety, MD
University of California, San Francisco, CA
Elaine Koogler, Stakeholder
Prince Frederick, MD
Christine Laronga, MD
Moffitt Cancer Center, University of South Florida, Tampa, FL
Susan K. Logan, PhD
New York University, New York, NY
Walter G. O'Dell, PhD
University of Rochester, Rochester, NY
Jacek Pinski, MD, PhD
University of Southern California - Norris Cancer Center and Hospital,
Los Angeles, CA
Matthew Robinson, PhD
Fox Chase Cancer Center, Philadelphia, PA
Elaine Smith
University of Iowa, Iowa City, IA
Karen K. Smith-McCune, MD, PhD
University of California, San Francisco, CA
Xifeng Wu
M.D. Anderson Cancer Center, University of Texas, Houston, TX
Raymond B. Wynn, MD
University of South Alabama, Mobile, AL
Lei Xing, PhD
Stanford University, Stanford, CA
Paul J. Yazaki, PhD
Beckman Research Institute of the City of Hope, Duarte, CA
Kristine Marie Zanotti, MD
Cleveland Clinic Foundation, Cleveland, OH
|
